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TMEM16F activation by Ca2+ 
triggers plasma membrane 
expansion and directs PD-1 
trafficking
Christopher Bricogne1, Michael Fine2, Pedro M. Pereira  3, Julia Sung4, Maha Tijani4, 
Youxue Wang2, Ricardo Henriques  3, Mary K. Collins1,4,5 & Donald Hilgemann2
TMEM16F is a Ca2+ -gated ion channel that is required for Ca2+ -activated phosphatidylserine exposure 
on the surface of many eukaryotic cells. TMEM16F is widely expressed and has roles in platelet 
activation during blood clotting, bone formation and T cell activation. By combining microscopy and 
patch clamp recording we demonstrate that activation of TMEM16F by Ca2+ ionophores in Jurkat 
T cells triggers large-scale surface membrane expansion in parallel with phospholipid scrambling. 
With continued ionophore application,TMEM16F-expressing cells then undergo extensive shedding 
of ectosomes. The T cell co-receptor PD-1 is selectively incorporated into ectosomes. This selectivity 
depends on its transmembrane sequence. Surprisingly, cells lacking TMEM16F not only fail to expand 
surface membrane in response to elevated cytoplasmic Ca2+, but instead undergo rapid massive 
endocytosis with PD-1 internalisation. These results establish a new role for TMEM16F as a regulator of 
Ca2+ activated membrane trafficking.
Eukaryotic cells retain phosphatidylserine (PS) on the cytoplasmic face of the plasma membrane1. In response 
to high levels of cytoplasmic Ca2+ elevation and during apoptosis, PS is exposed on the cell surface by a process 
known as phospholipid scrambling2. Ca2+-activated phospholipid scrambling is mediated by a transmembrane 
protein, TMEM16F (also known as anoctamin 6)3,4, a widely expressed member of the TMEM16 family of ion 
channels5. In platelets, Ca2+-activated PS exposure is an important step in blood coagulation, and the main phe-
notype caused by TMEM16F mutations in humans is a bleeding disorder called Scott Syndrome3,6. In contrast, 
PS exposure during apoptosis, which marks cells for removal by phagocytosis7, does not depend on TMEM16F3.
There is evidence that TMEM16F itself acts as both a Ca2+-activated ion channel and phospholipid “scram-
blase”. These two functions are activated simultaneously following a large increase in intracellular Ca2+ 4. Recent 
work employing single molecules of purified mouse TMEM16F incorporated into membrane microarrays8, 
as well as reconstitution experiments of a fungal TMEM16 homologue in liposomes9,10, support the idea that 
TMEM16F can facilitate bidirectional diffusion of phospholipids. The crystal structure of the fungal TMEM16 
reveals a hydrophilic groove that may serve as the channel for both ions and lipids10. In addition, a 35 amino acid 
scrambling domain identified in TMEM16F can confer this function on TMEM16A, a relative of TMEM16F that 
does not scramble phospholipids4,11.
Mice lacking TMEM16F suffer from immune exhaustion leading to a failure to clear viral infections12. This 
is at least in part due to a failure to down-regulate PD-1, which is highly expressed on T cells in TMEM16F-null 
mice during lymphocytic choriomeningitis virus (LCMV) infection12. PD-1 is a negative regulator of the immune 
system, which can be hijacked by various cancers to evade anti-tumour immune responses; antibodies that block 
PD-1 function are potent cancer therapeutics13. Thus, TMEM16F-dependent regulation of PD-1 expression on 
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the cell surface may be of immunological and clinical significance. The mechanism by which PD-1 expression on 
T lymphocytes is regulated by TMEM16F has not been explained.
A role for TMEM16F in membrane trafficking has, however, been reported in several other cell types. 
For example, TMEM16F is involved in microvesicular release from platelets and neutrophils14. Mice lacking 
TMEM16F show deficits in bone development15, a process that is linked with microvesicle release from oste-
oblasts16. In macrophages TMEM16F is necessary for phagocytosis stimulated by the ATP receptor P2X717 and 
microglia lacking TMEM16F demonstrate defects in process formation and phagocytosis18.
In T lymphocytes, the triggering of the antigen receptor causes a large cytoplasmic Ca2+ elevation that can 
be mimicked by addition of an ionophore such as ionomycin19. In this paper we show that cytoplasmic Ca2+ 
elevations induced by ionomycin cause rapid plasma membrane expansion in parallel with PS exposure in Jurkat 
T cells. The absence of TMEM16F blocks both membrane expansion and PS exposure in response to elevated 
cytoplasmic Ca2+, which surprisingly leads instead to massive endocytosis of the plasma membrane in the cells 
lacking TMEM16F. We further find that in Jurkat T cells, PD-1 is selectively shed in vesicles after TMEM16F 
activation, while it is selectively internalised in the absence of TMEM16F. This behaviour of PD-1 depends on its 
transmembrane region sequence, and other membrane proteins did not show such behaviour. These results pro-
vide a potential explanation for the TMEM16F regulation of PD-1 cell surface expression described previously12.
Results
Ca2+ influx triggers PS exposure and plasma membrane expansion. As previously reported for 
mouse T lymphocytes12, treatment of Jurkat T cells with the calcium ionphore ionomycin led to an increase in 
cytoplasmic Ca2+ (measured by Fluo-4 fluorescence) and surface exposure of PS (detected by annexin V staining) 
(Fig. 1A).
We had previously observed large changes in plasma membrane area when PS was exposed by Ca2+ ionophore 
treatment in BHK cells20. We therefore examined whether the plasma membrane (PM) area of Jurkat T cells 
changed when they were exposed to ionomycin. PM area was quantified by patch clamp recording of membrane 
capacitance (Cm), which is proportional to membrane area. We also measured membrane conductance (Gm) 
which measures the voltage-dependent movement of ions across the PM. Confocal microscopy of the patched 
cell was used to measure the surface binding of the fluorescent membrane dye FM4-64. During a 20 second expo-
sure to ionomycin, Cm of the Jurkat T cell showed a striking doubling in plasma membrane area (Fig. 1B, Cm red 
trace), and FM4-64 dye binding also increased dramatically (Fig. 1B solid shape number 3, Fig. 1B micrograph 
3, Supplementary Video S1). FM4-64 binding was fully reversible when the dye was removed, indicating that the 
dye was not internalised (Fig. 1B solid shape 3 to 4, Fig. 1B micrograph 4). Interestingly, the PM conductance of 
the Jurkat T cell increased substantially and then declined in parallel with the rise in capacitance (Fig. 1B. Gm, blue 
trace), consistent with the transient opening of a Ca2+ -gated ion channel at the time of membrane expansion.
TMEM16F regulates cytoplasmic Ca2+-activated PM expansion. TMEM16F has been reported to 
act as a Ca2+-dependent phospholipid scramblase3 as well as a Ca2+ -gated ion channel6. We therefore tested 
whether our observations in Fig. 1 depended on TMEM16F by deleting it from Jurkat T cells using CRISPR/
Cas9 to target TMEM16F exon 2. The sequence of exon 2 from a single cell clone isolated from the targeted cells 
showed three different single base pair insertions at the same position, suggesting this gene is present in three 
copies in Jurkat T cells (Supplementary Fig. S2C). In each case the base pair insertion was predicted to generate 
an in frame stop codon, truncating TMEM16F after 50 amino acids (Supplementary Fig. S2D). Antibodies against 
human TMEM16F did not reliably detect TMEM16F in Jurkat T cell lysates. We therefore conducted proteomic 
analysis of membrane preparations from wild-type and exon 2 CRISPR/Cas9 targeted cells (Supplementary 
Fig. S3). Data comparing TMEM16F peptides to three other representative membrane proteins demonstrate 
that the CRISPR/Cas9 targeted cells lack TMEM16F protein within the limits of detection. In addition, the 
TMEM16F-null cells failed to externalise PS in response to ionomycin despite a large increase in intracellular 
Ca2+, as previously reported for mouse T lymphocytes12 (Fig. 2A, Supplementary Fig. S2H). These results could 
be replicated in an independent cell clone derived from Jurkat T cells using CRISPR/Cas9 to target TMEM16F 
exon 5 (Supplementary Fig. S2E–H), the exon 2 targeted cell clone was used for all subsequent experiments.
In patch clamp recordings of Exon 2-targeted TMEM16F-null cells, the Ca2+-activated increase in conduct-
ance was also abolished (Fig. 2B, Gm blue trace), consistent with the idea that the Ca2+ -gated ion channel that 
we detected in Fig. 1B was indeed due to TMEM16F. Remarkably, in the TMEM16F-null cells PM area decreased 
by 50% upon ionomycin treatment (Fig. 2B, red trace), compared to the doubling in plasma membrane area 
observed in the wild-type Jurkat T cells (Fig. 1B, Cm red trace). This decrease in membrane area was due to PM 
internalisation, as FM4-64 binding became irreversible after ionomycin treatment (Fig. 2B solid shape 3 to 4) and 
could be detected in membrane structures below the cell surface (Fig. 2B micrograph 4, Supplementary Fig. S4. 
The kinetics of this endocytic response are consistent with a rapid form of Ca2+-activated massive endocytosis 
(MEND) that we have described previously in fibroblasts and that becomes activated in the presence of cytoplas-
mic polyamines, such as spermine and spermidine21. In further support of the idea that this endocytosis repre-
sents MEND, endocytic responses were not blocked by inhibiting clathrin with K+-free cytoplasmic solutions, or 
by a dynamin inhibitor, or by perturbing the actin cytoskeleton with latrunculin or phalloidin (Supplementary 
Fig. S5A).
The increase in intracellular Ca2+ triggered by ionomycin addition to Jurkat cells is actually similar to that 
resulting from maximal TCR triggering in this cell line19. However, many physiological cell stimuli and many pri-
mary cell types show smaller intracellular Ca2+ increases in response to receptor signalling. We therefore buffered 
free intracellular Ca2+ using EGTA and examined the effect of a more modest (3 μM) increase in free intracellular 
Ca2+. Supplementary Fig. S5B shows that this level of free intracellular Ca2+ causes a clear expansion in plasma 
membrane in the presence of TMEM16F, and substantial loss of plasma membrane when TMEM16F is absent. 
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It is noteworthy that this level of free intracellular Ca2+ is substantially lower than the 100 μM free intracellular 
Ca2+ often used to studty TMEM16F function (for example)6, and therefore TMEM16F regulation by receptor 
signaling in some circumstances remains likely.
Ca2+-activated PS exposure and PM expansion is followed by vesicle shedding. We next inves-
tigated the timing of PS exposure and membrane expansion after ionomycin treatment. To detect PS exposure, 
we used a rhodamine labelled cationic peptide, heptalysinerhodamine (K7r), rather than annexin V. K7r binds 
anionic phospholipids more rapidly than annexin V and does not require Ca2+-containing buffers for binding20. 
Figure 3A illustrates imaging of a single field of Jurkat T cells, measuring cytoplasmic Ca2+ using Fluo-4-AM 
(green), and PS exposure (red) using K7r. Treatment with ionomycin resulted in increases in cytoplasmic Fluo-4 
fluorescence followed after 45 seconds by PM labelling with K7r. The full video of this experiment with unpatched 
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Figure 1. Surface phosphatidylserine exposure and plasma membrane expansion in Jurkat T cells treated 
with ionomycin. (A) Jurkat T cells were incubated with the cytoplasmic calcium indicator Fluo4-AM, then 
treated with 5 μM ionomycin for 15 minutes at 37 °C. Cells were then chilled on ice and stained with Annexin 
V (Anx V) to detect surface phosphatidylserine. Flow cytometry analysis shows intracellular calcium plotted 
against surface phosphatidylserine. (B) Single Jurkat T cells were patched with a glass micropipette loaded 
with cytoplasmic solution (see Materials and Methods) and incubated at 37 °C in Ringer’s solution. Cells were 
then treated with 5 μM ionomycin for the period shown. Measurements were made of total capacitance, Cm, 
which reflects plasma membrane area, and transmembrane conductance, Gm. The red trace shows the change 
in capacitance (∆Cm) compared to t = 0, while the blue trace shows Gm. A typical ∆Cm trace is shown, the error 
bar represents standard error of the mean (SEM) at 150 s post ionomycin addition (n = 10). In addition, the dye 
FM4-64, which binds reversibly to membranes, was added to the same patched cell and removed as shown. The 
solid trace shows total FM4-64 fluorescence of the cell, measured by a confocal microscope, relative to t = 0. 
Below are images taken using confocal microscopy at the time points shown (scale bar is 5 μm).
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expansion, Cm (red trace), and PS exposure, K7r (green trace) in a single patch-clamped Jurkat T cell. The two sig-
nals followed an identical time course within the detection limits of the experiment, suggesting that PS exposure 
and PM expansion are linked processes. Subsequent to PM expansion and PS exposure, the two fluorescence sig-
nals declined in parallel. The fact that the K7r signal was not maintained as Cm declined, (Fig. 3B), suggested that 
the excess PM was shed rather than endocytosed. Vesicle shedding preceeded by membrane protrusions could 
be detected when FM4-64-stained Jurkat T cells were treated with ionomycin and followed by video microscopy 
(Supplementary Video S1).
In order to follow the fate of this shed membrane we treated wild-type and TMEM16F-null Jurkat T cells with 
ionomycin for 10 minutes, then stained the cultures with Fluor®780, a membrane impermeable dye. Flow cytom-
etry was then used to analyse subcellular-sized events, which were separated into those with intact membranes, 
or those with ruptured membranes by Fluor®780 staining (Fig. 3C). All cultures contained similar levels of sub-
cellular, membrane permeable particles. However, Ca2+-ionophore treatment of WT but not TMEM16F-null 
Jurkat T cells resulted in a large increase of subcellular events with an intact membrane, consistent with a 
TMEM16F-dependent release of membrane vesicles.
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FM4-64 binding to patched cell
Figure 2. Plasma membrane internalization in TMEM16F-null Jurkat T cells treated with ionomycin. (A) 
TMEM16F-null Jurkat T cells were incubated with the cytoplasmic calcium indicator Fluo4-AM, then treated 
with 5 μM ionomycin for 15 minutes at 37 °C. Cells were then chilled on ice and stained with Annexin V (Anx 
V) to detect surface phosphatidylserine. Flow cytometry analysis shows intracellular calcium plotted against 
surface phosphatidylserine. (B) Single TMEM16F-null Jurkat T cells were patched with a glass micropipette 
loaded with cytoplasmic solution (see Materials and Methods) and incubated at 37 °C in Ringer’s solution. 
Cells were then treated with 5 μM ionomycin for the period shown. Measurements were made of total 
capacitance, Cm, which reflects plasma membrane area, and transmembrane conductance, Gm. The red trace 
shows the change in capacitance (∆Cm) compared to t = 0, while the blue trace shows Gm. A typical ∆Cm 
trace is shown, the error bar represents standard error of the mean (SEM) at 150 s post ionomycin addition 
(n = 10). In addition, the dye FM4-64, which binds reversibly to membranes, was added to the same patched 
cell and removed as shown. The solid trace shows total FM4-64 fluorescence of the cell, measured by a confocal 
microscope, relative to t = 0. Below are images of FM4-64 fluorescence taken using confocal microscopy at the 
time points shown (scale bar is 5 μm).
www.nature.com/scientificreports/
5SCIeNTIFIC RepoRts |           (2019) 9:619  | DOI:10.1038/s41598-018-37056-x
Relationship between TMEM16F cation conduction and PM expansion. TMEM16F is also 
reported to act as a non-selective cation channel6. We therefore investigated the relationship between monovalent 
cation transport and PM expansion during TMEM16F activation. Figure 4 shows the result for patched Jurkat 
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Figure 3. Simultaneous surface phosphatidylserine exposure and plasma membrane expansion is followed by 
membrane vesicle shedding. (A) Jurkat T cells were loaded with the cytoplasmic calcium indicator Fluo4-AM, 
then treated with 5 μM ionomycin for 400 s at 37 °C in the presence of polylysine-rhodamine (K7r) which 
binds rapidly to exposed phosphatidylserine. Confocal microscope images of Fluo4-AM and K7r fluorescence 
in a single field of cells are shown (scale bar is 10 μm). (B) A single TMEM16F-null Jurkat T cells was patched 
with a glass micropipette loaded with cytoplasmic solution (see Materials and Methods), incubated at 37 °C in 
Ringer’s solution, then treated with 5 μM ionomycin at the time shown. Total capacitance, Cm, was measured 
and the red trace shows the change in capacitance (∆Cm) compared to t = 0. In addition, K7r was added to the 
same patched cell and removed as shown. The green trace shows total K7r fluorescence of the cell, measured by 
a confocal microscope, relative to t = 0. Below are images of K7r fluorescence taken using confocal microscopy 
at the time points shown (scale bar is 5 μm). (C) Wild-type or TMEM16F-null Jurkat T cells were treated with 
5 μM ionomycin for 15 minutes in the presence of eFluor780, a plasma membrane impermeable dye. The cell 
preparations were analyzed by FACS. The events shown were first gated on subcellular sized particles using 
forward scatter and side scatter. Staining of these subcellular particles is displayed versus side scatter, with 
unstained events representing dye impermeable membrane vesicles rather than apoptotic bodies. The numbers 
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Figure 4. Membrane expansion occurs in parallel with conductance and current changes and requires the 
presence of monovalent cations. (A) Single Jurkat T cells were patched with a glass micropipette loaded with 
cytoplasmic solution (see Materials and Methods) and incubated at 37 °C in Ringer’s solution. Cells were treated 
with 5 μM ionomycin for the period shown. Measurements were made of total capacitance, Cm, transmembrane 
conductance, Gm (lower blue trace), and transmembrane current Im (lower green trace). The upper red trace 
shows the change in capacitance (∆Cm), while the upper blue trace shows the integral ∫Gm. Records were scaled 
to start and end at the same time, n = 10. (B) Membrane expansion was recorded as in ‘A’ and monovalent cation 
concentrations employed were varied as indicated.
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conductance (Gm) were also measured. Cytoplasmic Ca2+ elevation was induced by ionomycin treatment. As 
shown in Fig. 4A, the time course of increase in Cm closely followed the time courses of membrane current (Im) 
and conductance (Gm) changes. The integral of the Gm signal corresponds closely to the time course of the Cm 
signal, after scaling (>20 observations). This suggests that PM expansion is directly dependent on the activa-
tion state of TMEM16F. Expansion begins as TMEM16F channels open and terminates as TMEM16F channels 
inactivate.
Given this close relationship, we next tested whether monovalent cations that permeate TMEM16F affect PM 
expansion (Fig. 4B). To do so, we varied the monovalent content of experimental solutions systematically. From 
left to right, the results shown that substitution of >90% of Cl for aspartate (As) was without effect, that both cyto-
plasmic K and extracellular Na could support extensive PM expansion in the presence of NMDG (Nm) on the 
opposite membrane side, that that presence of Nm on both membrane sides reduced expansion by ~60%, that the 
nearly impermeable cation, TEA, reduced expansion by ~75%, and that substitution of 90% of monovalent ions 
for sucrose abolished membrane expansion. While these data demonstrate that membrane expansion requires 
monovalent cations, the ability of both cytoplasmic K and extracellular Na to support expansion excludes the idea 
that either cation efflux or influx catalyzes membrane expansion.
TMEM16F mutations modulate its function. We next examined the activity of TMEM16F mutants that 
are reported to have modified scrambling activity3,6,22. In these experiments we used patch clamped HEK 293 cells 
that constitutively overexpress the NCX1 Na+/Ca2+ exchanger20. This allows the generation of a transient increase 
in cytoplasmic Ca2+, by elevating external Ca2+, without the use of ionomycin. Figure 5A (red trace) shows that 
these HEK 293 cells also responded to a cytoplasmic Ca2+ increase with a modest PM expansion, an effect that 
was augmented by over-expression of murine TMEM16F (mTMEM16F) (Fig. 5A, blue trace).
We then used the same CRISPR/Cas9 targeting exon 2 to create a TMEM16F-null HEK 293 cell line overex-
pressing the NCX1 Na/Ca exchanger. As in Jurkat cells, Ca2+ influx in TMEM16F-null HEK293 cells caused rapid 
MEND (Fig. 5B, red trace), and both membrane expansion (Fig. 5B, blue trace) and PS exposure induced by either 
increasing extracellular [Ca2+] or addition of ionomycin (Fig. 5C, blue bars) could be restored by over-expressing 
mTMEM16F. The D430G mutant was reported to have constitutive PS scrambling activity3, however, we saw no 
difference in PS exposure between mTMEM16F and the D430G mutant, in agreement with a more recent report6 
(Fig. 5C, orange bar). In line with this result, we further demonstrated no difference in membrane expansion by 


























0 1 2 3 4 5 6 7





Control WT HEK293 B TMEM16F-null HEK293






Figure 5. Plasma membrane expansion activity of TMEM16F mutants (A) Single HEK293 cells stably 
expressing the cardiac Na/Ca exchanger (NCX1.1) were patched with a glass micropipette loaded with 40 mM 
Na+; transient increase of extracellular [Ca2+] to 2 mM (at the time shown) was used to induce an increase 
in intracellular Ca2+. The change in membrane capacitance (∆Cm) was measured and the percentage change 
was calculated. Single recordings are displayed, mean values at 30 s, 45 s and 60 s after stimulation are shown 
(+/−SEM, n = 7). Upper red trace, control cells; lower blue trace, cells over-expressing murine TMEM16F. (B) 
Single TMEM16F-null HEK293 cells stably expressing the cardiac Na/Ca exchanger (NCX1.1) were patched 
with a glass micropipette loaded with 40 mM Na+; transient increase of extracellular [Ca2+] to 2 mM (at the 
time shown) was used to induce an increase in intracellular Ca2+. The change in membrane capacitance (∆Cm) 
was measured and the percentage change was calculated. Single recordings are displayed with mean values 
at 30 s, 45 s and 60 s after stimulation shown (+/−SEM, n = 7). Upper red trace, control cells; lower traces, 
cells over-expressing murine TMEM16F and mutants as shown. (C) Single TMEM16F-null HEK293 cells 
stably expressing the cardiac Na/Ca exchanger (NCX1.1) were patched with a glass micropipette loaded with 
40 mM Na+; a transient increase of extracellular [Ca2+] to 2 mM was used to induce an increase in intracellular 
Ca2+ in the presence of the phosphatidylserine binding dye K7r. In the case of “WT rescue (iono)” cells were 
treated with 5 μM ionomycin instead. The total fluorescence of each cell was measured at 60 s using a confocal 
microscope, and the percentage change compared to untreated was calculated. Mean values are shown (+/−
SEM, n = 7; **p < 0.01, ns, not significant, Student t-test).
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and slows activation kinetics6, had diminished PS exposure (Fig. 5C, black bar). Notably, however, the resid-
ual function of the Q559K mutant was sufficient to prevent the MEND response seen in TMEM16F-null cells 
(Fig. 5B, black trace).
We have previously reported that polyamines, which can modulate the activity of ion channels23, can switch 
Ca2+-induced membrane expansion to fast MEND responses in fibroblasts21, reminiscent of the effects of delet-
ing TMEM16F. As shown in Fig. S7, spermine at physiological concentrations (up to 500 μM) also changed the 
ionomycin-induced Jurkat T cell PM expansion to MEND. The TMEM16F conductance was also blocked by 
spermine. This might reflect either a direct block of the TMEM16F pore or binding of anionic lipids that appear 
to regulate TMEM16F activity as recently demonstrated for PIP224. Given that TMEM16F conductance invari-
ably decreases as PS is lost from cytoplasmic leaflette, we suggest that cytoplasmic PS may also support channel 
activity. As in the case of the Q559K mutant of TMEM16F, an intermediate concentration of spermine inhibited 
membrane expansion and did not lead to MEND in response to ionomycin.
PD-1 is shed in vesicles after Ca2+-activated PM expansion. We next investigated the surface expres-
sion of T cell proteins following Ca2+-ionophore treatment. Initially, we examined the regulation of PD-1, as 
TMEM16F has been implicated in control of PD-1 surface expression12. PD-1 was expressed only at low levels in 
Jurkat T cells so we upregulated irs expression with PHA and showed that ionophore treatment resulted in rapid 
PD-1 down-regulation (Fig. S8). The same effect could be seen in PBML, where OKT3 upregulated PD-1 on a 
subset of cells. This up-regulated PD-1 was rapidly down-regulated by ionomycin treatment (Fig. S8). To track 
PD-1 during membrane expansion and shedding, we engineered Jurkat T cells to constitutively express a PD-1/
GFP chimera. Figure 6A shows that both endogenous and chimeric PD-1 were the most down-regulated surface 
proteins among those that we studied, including the co-receptor CD28, the adhesion molecules ICAM-1 and 
LFA-1, and the highly expressed transferrin receptor and HLA-A, -B and -C. We then used the PD-1/GFP fusion 
protein to analyse the cause of this decrease in surface expression. Figure 6B shows that approximately 50% of the 
PD-1/GFP fluorescence was lost from the cells on ionophore treatment. We reasoned that the extent of PD-1/GFP 
loss was not as great as the loss of PD-1 surface staining because some of the PD-1/GFP was present intracellu-
larly (as demonstrated by PD-1/mCherry fluorescence, used for compatibility with the microscope, in Fig. 6D). 
In order to examine which part of the PD-1 molecule controlled shedding, we constructed chimeras between 
PD-1 and HLA-A2, as HLA staining did not change significantly in response to ionophore treatment (Fig. 6A). 
The most informative chimeras are shown in Fig. 6C, both proteins have the PD-1 extracellular domain and the 
HLA-A2 intracellular domain while one had the PD-1 transmembrane domain (PD1TM), while the other had 
the HLA-A2 transmembrane domain (HLATM). Figure 6C shows that the transmembrane domain of PD-1 was 
necessary for its down-regulation after ionophore treatment.
We then investigated whether PD-1 was shed in vesicles, using both microscopy and flow cytometry. In order 
to permit detection by Structured Illumination Microscopy (SR-SIM), we used a PD-1/mCherry fusion protein, 
as opposed to PD-1/GFP for compatibility with the microscope. Figure 6D shows that we could detect fluorescent 
vesicles after ionomycin treatment and Supplementary Fig. S9 is a video of this experiment. When we used flow 
cytometry to detect subcellular sized events with intact membranes we found vesicles containing PD-1, detected 
by both antibody staining and GFP fluorescence, in the supernatant of cells 15 minutes after ionomycin treatment 
(Fig. 6E).
PD-1 is internalized in cells lacking TMEM16F. We next examined PD-1 expression in TMEM16F-null 
cells using antibody staining and found that this decreased substantially following ionomycin treatment (Fig. 7A). 
In this case, however, the PD-1/GFP chimera was not lost from the cells when GFP fluorescence was measured 
after ionomycin treatment, though it disappeared from the cell surface suggesting that it had been internalized, 
presumably by endocytosis (Fig. 7B). Comparison of the PD1 and HLA-A2 chimeras demonstrated that the PD-1 
transmembrane domain was required for PD-1 down-regulation in response to ionomycin (Fig. 7C). Finally, 
the PD-1/mCherry chimera could be found in large intracellular vesicles after ionophore treatment (Fig. 7D, 
Supplementary Video S10) suggesting that that it is internalized by endocytosis during MEND in TMEM16F-null 
cells.
Discussion
How are TMEM16F-induced membrane expansion, PS exposure and ion conduction related? 
These data demonstrate that TMEM16F can act as a cytoplasmic Ca2+ sensor/effector for large-scale membrane 
expansion (Figs 1 and 3–5), in addition to its previously known functions as a phospholipid scramblase and an 
ion channel. Membrane expansion closely followed the kinetics of PS exposure (Fig. 3), suggesting interdepend-
ence of these activities. Significantly, membrane expansion activity was impaired by a mutation (Q559K) that 
affects the ion selectivity, activation kinetics and phospholipid scrambling activity of TMEM16F (Fig. 5)6,22. The 
mechanism of large-scale membrane expansion is not at all clear from these data. The major possibility raised 
is that phospholipid scrambling in some way triggers PM expansion, where by loss of cytoplasmic PS or a gain 
of extracellular PS might play critical roles. The present data also do not exclude a possibility that TMEM16F-
activated PS exposure reflects the fusion of intracellular membranes that have randomised phospholipids25,26. 
The fact that both cytoplasmic K and extracellular Na can support membrane expansion (Fig. 4) rules out the 
possibilies that cation efflux or cation influx per se might triggers PM expansion by changing local cation con-
centrations. Rather, cations must be playing some other structural or catalytic roles in the PM expansion process, 
possibly related to phospholipid scrambling.
The identity of the membranes that fuse with the cell surface, and whether this occurs by canonical exo-
cytosis or by some other mechanism, remain unanswered questions from the present results. Compartments 
that may in principle be involved include lysosomes, ER, recycling endosomes, Golgi-derived tubules25,27, and a 
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poorly understood membrane compartment dubbed ‘enlargeosomes’ in previous studies28. Further investigation 
is clearly essential to resolve both the mechanistic and structural basis of TMEM16F-dependent PM expansion.
How does TMEM16F prevent endocytosis? We were surprised to find that the presence or absence of 
TMEM16F determines whether large amounts membrane are added to or removed from the PM in response to 
an increase in cytoplasmic Ca2+ (Figs 1 and 2). It appears that TMEM16F blocks endocytosis in response to Ca2+ 
influx via ionphore addition, because the TMEM16F mutant Q559K (Fig. 5) showed neither PM expansion nor 
endocytosis.This suggests that a minimally active TMEM16F is sufficient to block endocytosis. Furthermore, the 
presence of a polyamine, spermine, that blocks TMEM16F conductance also blocks PM expansion and promotes 
endocytosis (Supplementary Fig. S7). Similar results obtained for spermidine in BHK cells supports the idea 
that block of TMEM16F activity supports endocytosis by nonconventional mechanisms21. For example, it may 
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Figure 6. Wild-type Jurkat T cells shed PD-1 upon treatment with ionomycin (A) Control wild-type Jurkat 
T cells over-expressing a PD-1/GFP chimera were treated with 5 μM ionomycin for 15 minutes at 37 °C for 
15 minutes then chilled and stained at 4 °C for expression of a variety of surface molecules and analyzed by 
FACS. Data shows the percentage of initial surface expression after ionomycin treatment. (B) Control wild-type 
Jurkat T cells over-expressing a PD-1/GFP chimera were treated with 5 μM ionomycin for 15 minutes at 37 °C 
then chilled and stained at 4 °C for PD-1 expression. PD-1 staining and cellular GFP expression were analyzed 
by FACS; data shows the percentage of initial expression after ionomycin treatment. (C) Control wild-type 
Jurkat T cells over-expressing a PD-1/GFP chimera, or a PD-1/GFP chimera where the PD-1 transmembrane 
sequence was replaced by that from HLA-A2, were treated with 5 μM ionomycin for 15 minutes at 37 °C then 
chilled and stained at 4 °C for PD-1 expression. PD-1 staining was analyzed by FACS; data shows the percentage 
of initial expression after ionomycin treatment. (D) Control wild-type Jurkat T cells over-expressing a PD-1/
mCherry chimera, were imaged by SR-SIM microscopy before and after ionomycin treatment. Arrows indicate 
fluorescent vesicles (scale bar is 5 μm). (E) Control wild-type Jurkat T cells, or control wild-type Jurkat T 
cells over-expressing a PD-1/GFP chimera, were stained with an anti-PD-1 antibody, then treated with 5 μM 
ionomycin for 15 minutes at 37 °C in the presence of fixable viability dye eFluor780. The cell preparations were 
analyzed by FACS. The events shown were first gated on subcellular sized events (low forward scatter) and 
intact membranes (low fixable viability dye eFluor780 staining). PD-1 and GFP expression in these gated events 
is shown. Cellular FACS data shows the mean +/− SEM for three independent experiments. (***p < 0.001, 
**p < 0.01, Student t-test).
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Alternatively cytoplasmic PS may be required for endocytosis, and its loss via TMEM16F-mediated scrambling 
accordingly blocks this form of fast Ca2+-activated MEND.
What is the role of TMEM16F in membrane shedding and PD-1 regulation? We have described 
that TMEM16F-dependent PM expansion leads to extensive shedding of membrane vesicles from the PM as 
ectosomes (Fig. 3). Previous reports demonstrate that TMEM16F-null erythrocytes do not produce vesicles in 
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Figure 7. TMEM16F-null Jurkat T cells internalise PD-1 upon treatment with ionomycin (A) TMEM16F-null 
Jurkat T cells over-expressing a PD-1/GFP chimera were treated with 5 μM ionomycin for 15 minutes at 37 °C 
for 15 minutes then chilled and stained at 4 °C for expression of a variety of surface molecules and analyzed by 
FACS. Data shows the percentage of initial surface expression after ionomycin treatment. (B) TMEM16F-null 
Jurkat T cells over-expressing a PD-1/GFP chimera were treated with 5 μM ionomycin for 15 minutes at 37 °C 
then chilled and stained at 4 °C for PD-1 expression. PD-1 staining and cellular GFP expression were analyzed 
by FACS; data shows the percentage of initial expression after ionomycin treatment. (C) TMEM16F-null 
Jurkat T cells over-expressing a PD-1/GFP chimera, or a PD-1/GFP chimera where the PD-1 transmembrane 
sequence was replaced by that from HLA-A2, were treated with 5 μM ionomycin for 15 minutes at 37 °C then 
chilled and stained at 4 °C for PD-1 expression. PD-1 staining was analyzed by FACS; data shows the percentage 
of initial expression after ionomycin treatment. (D) TMEM16F-null Jurkat T cells over-expressing a PD-1/
mCherry chimera, were imaged by SR-SIM microscopy before and after ionomycin treatment. Arrows indicate 
fluorescent vesicles (scale bar is 5 μm). Cellular FACS data shows the mean +/− SEM for three independent 
experiments. (****p < 0.0001, **p < 0.01, Student t-test).
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bone mineralization31 which would explain why TMEM16F-null mice have defective embryonic bone formation: 
they are unable to produce such vesicles32.
In the case of T cells, the shed membrane vesicles express the immune inhibitor PD-1, which would account 
for the reduction of PD-1 on the cell surface (Fig. 7). Hu and colleagues12 found that TMEM16F-deficient T cells 
exhibited high PD-1 expression. This was accompanied by immune exhaustion and impaired anti-viral immunity. 
They detected TMEM16F in endosomes at the immunological synapse in T cells, and suggested that TMEM16F 
limits PD-1 surface expression, by causing its endocytosis. To the contrary, our data suggest that it is the shed-
ding of PD-1 that accounts for its down-regulation. The fact that TMEM16F-deficient T cells exhibited high 
PD-1 expression also leads to the conclusion that down-regulation of PD-1 by MEND does not occur in mice, 
perhaps because of other known defects in TCR signalling in these exhausted cells12. The observation that the 
PD-1 transmembrane region controls its association with membrane that is either shed in vesicles or endocytosed 
(Figs 6 and 7) suggests that particular transmembrane domains must be involved in cytoplasmic Ca2+-stimulated 
trafficking.
Vesicle shedding from T cells can be a localised phenomenon following TCR triggering33. Our study is lim-
ited in that we have used a T cell line that is amenable to patch-clamp experiments, and a non-physiological 
Ca2+-ionophore stimulus to induce whole cell responses so that we can measure bulk plasma membrane changes 
using capacitance. Future studies of the role of TMEM16F measuring local vesicle shedding in primary T cells 
following receptor triggering are therefore warranted.
What is the role of TMEM16F in membrane repair? It has long been recognised that cells can rapidly 
repair mechanical damage to their PM34. This is one of the processes that we are mimicking when we induce a 
large increase of cytoplasmic Ca2+ using an ionophore. TMEM16F has a high Ca2+ threshold for activation4,6 and 
membrane trafficking events triggered by similarly high Ca2+ levels occur during membrane repair. A physical 
lesion or a pore-forming toxin increases the cytoplasmic Ca2+ concentration by up to a hundred-fold, which has 
been reported to cause exocytosis35, endocytosis20,36, and/or membrane shedding37,38. Thus one potential func-
tion of Ca2+-stimulated exocytosis dependent on TMEM16F may be membrane repair, with the expression level 
or activity of TMEM16F controlling whether cells respond by exocytosis or endocytosis. Indeed, physiological 
membrane damage and repair in animals have been most extensively studied in muscle35 where mechanical dam-
age induces Ca2+-dependent membrane repair. Deficiency in TMEM16E, a close family member of TMEM16F, 
causes a muscular dystrophy that is linked to defective membrane fusion and repair39. It remains to be established 
whether TMEM16F is involved in membrane repair in other cell types.
Materials and Methods
Data analysis was performed in Prism (GraphPad) or SigmaPlot (Systat) unless otherwise stated.
Cell lines, solutions and reagents. Jurkat E6.1 T cells (ECACC) were grown in RPMI-1640 (Sigma-Aldrich) 
while HEK-293 cells (Invitrogen) were grown in DMEM (Sigma-Aldrich). All media were supplemented with 
10% FCS (Invitrogen), 2 mM L-glutamine (Invitrogen) with 100 U/mL penicillin and 100 µg/mL streptomycin 
(Invitrogen). Standard cytoplasmic solution (Figs 1–5) contained (in mM) 145 KCl, 10 HEPES, 0.5 EGTA, 0.25 
CaCl2, 8 MgATP, 2 TrisATP and 0.2 GTP, adjusted to pH 7.4. Extracellular ‘Ringer’ solution (Figs 1–5) con-
tained (in mM) 145 NaCl, 10 HEPES, 2 CaCl2 and 2 MgCl2, adjusted to pH 7. Intracellular solution used in 
Fig. 4B contained (in mM) 100 NMDG, 40 NaOH, 140 aspartic acid, 0.5 EGTA, 0.25 CaCl2, 0.5 MgCl2, 10 HEPES 
adjusted to pH 7.0. K+-free N-Methyl-D-glucamine aspartate solution (Fig. S5) contained (in mM) 145 NMDG, 
10 HEPES, and 0.5 EGTA, adjusted to pH 7 with aspartic acid; 2 CaCl2 or 2 MgCl2 were added when solution 
was used on the extracellular side while 0.25 and 0.5, resp., were used on the cytoplasmic side. 5 μM ionomycin 
free acid (Calbiochem) was used unless otherwise stated. Other reagents used were: Lipofectamine 3000 (Life 
Technologies) for transient transfection protocols; 5 μM FM 4-64 (Life Technologies), and 50–500 μM spermine 
(Sigma-Aldrich). Rhodamine-conjugated hepta-lysine (rhodamine-KKKKKKK-amide; K7r) was prepared by 
Multiple Peptide Systems (NeoMPS, Inc.) and used at 3 μM. Compared to Annexin V, K7r was advantageous for 
real-time imaging as membrane binding is significantly faster, and K7r binding does not require Ca2+.
Whole-cell patch clamp with confocal imaging. Patch clamp recordings of cell electrical parameters 
were performed as described previously20 using Capmeter v6.340 with National Instruments digital acquisition 
boards and Axopatch 200B or 1D patch clamp amplifiers. Square-wave voltage perturbation (20 mV; 0.5 kHz) was 
employed, input resistances were 2–9 MΩ, and the apparent cell resistances were 0.1–2 GΩ. External solutions 
were kept at 35–37 °C in parallel gravity-fed solution lines with outlet flow rates of 2 to 5 mm/s. When confocal 
imaging and electrophysiology were combined, a Nikon TE2000-U microscope; 60 × oil immersion, 1.45-NA 
objective paired with the EZ-C1confocal system (Nikon) containing a 40-mW 163-Argon laser (Spectra Physics; 
Newport Corporation) operating at 488 nm at 7.5% maximum capacity for FM4-64 recordings and a 1.5 mW 
Melles Griot cylindrical HeNe laser at 543 nm at 55% of maximum capacity for K7r. Emission filters were set to 
either 500–540 nm or 580LP. Typical resolution was 512 × 512, set with a pixel dwell time yielding <1-s exposure 
times per frame and a pinhole of 150 μm. Image analysis was performed using either the EZ-C1 v3.9 (Nikon 
Instruments) or ImageJ (NIH). When imaging multiple fluorophores, sequential imaging was used to minimize 
spectral overlap. Photobleaching was negligible for these experiments. For independent confocal imaging of 
intact cells, 800 μl of media containing Jurkat cells was transferred to a glass bottom 4-chamber dish. Warmed 
ionomycin solution was rapidly added at a 5:1 concentration and cells were imaged as described. For patch clamp, 
intracellular calcium stimulus was triggered by direct perfusion of ionomycin for Jurkat and HEK cell lines. 
HEK cells stably expressing the cardiac Na/Ca exchanger (NCX1.1) were stimulated through reverse transport by 
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cytoplasmic pipette perfusion of cells with 40 mM Na+ and transient application of 2 mM Ca2+ to the extracellular 
solution20. No difference was detected in ionomycin or NXC induced stimulation of HEK cells (Fig. 5C).
CRISPR-Cas9 knockdown of TMEM16F. The lentiCRISPR v2 plasmid was used as described41. The guid-
eRNA sequence targeting TMEM16F Exon 2 was 5′-TCAGCATGATTTTCGAACCC-3′. HEK-293 cells were 
transiently transfected with plasmid using Lipofectamine (Life Technologies) and the lentivirus was collected 
from the supernatant. Jurkat T cells and HEK-293 cells were transduced with lentivirus produced using the 
gag-pol expression vector p8.91 and VSV-G envelope vector pMDG as described previously42. 48 hours after 
transduction cells were selected in 0.5 μg/ml Puromycin for Jurkat and 5 μg/ml Puromycin for HEK-293 before 
single-cell clones were isolated. Cells stably expressing Cas-9 and gRNA after transduction were frozen after ini-
tial expansion and aliquots thawed as needed to avoid accrued off-target effects resulting from long-term culture. 
Gene editing was confirmed by sequencing (Beckman Coulter) (Fig. S2). Two different primer sets were used to 
amplify Exon 2 (Set 1 and 2). Primer sequences were as follows (all 5′ - 3′):
Set 1 FW GTGCAGGTTCATGCTTCATTT,
Set 2 FW CCCGGTGCTGCTGATTTA,
Set 3 FW AGTGGTGGTCTCTGTATTGTTT
Proteomic analysis of Jurkat WT and CRISPR-Cas9 knock-out cells. Cells were subjected to Dounce 
homogenation on ice in 250 mM sucrose/10 mM Tris pH 7.4 with cOmplete protease inhibitor (Roche). Cell 
debris was pelleted and the supernatant was spun at 2000 g for 60 min to pellet membrane. Membranes were 
washed and reconstituted with 4 X Laemmli buffer for SDS-PAGE. Protein bands were excised and digested over-
night with trypsin (Pierce) following reduction and alkylation with DTT and iodoacetamide (Sigma-Aldrich). 
The samples underwent solid-phase extraction cleanup with Oasis HLB plates (Waters) and the resulting samples 
were analyzed by LC/MS/MS, using an Orbitrap Fusion Lumos mass spectrometer (Thermo Electron) coupled 
to an Ultimate 3000 RSLC-Nano liquid chromatography systems (Dionex). Raw MS data files were converted to 
a peak list format and analyzed using the central proteomics facilities pipeline (CPFP), version 2.0.343,44. Peptide 
identification was performed using the X!Tandem45 and open MS search algorithm (OMSSA) search engines 
against the human protein database from Uniprot, with common contaminants and reversed decoy sequences 
appended46. Label-free quantitation of proteins across samples was performed using SINQ normalized spectral 
index Software47.
Chimeric proteins, lentiviral vector constructs and production. All chimeric proteins were pro-
duced using overlap-extension PCR48 and cloned into a single (pSIN) or dual (pDUAL) promoter vector. In fluo-
rescent constructs a ‘GS’ linker separated PD-1 and fluorophore. Primers used to make PD1/GFP were PD1-FW, 
PD1GFP Sense, and PD1GFP Antisense GFP-RS. PD-1 mCherry was made in the same way using the primers 
PD1FW, PD1mCherry Sense, PD1mCherry Antisense and mCherry RS. PD1HLA Chimers were made with 
PD1-FW and HLA-A2-RS. For PD-1HLA-A2 chimeras, the extracellular portion was always PD-1 and the intra-
cellular HLA-A2. The TM regions were the only sequences to vary between the two constructs. The transmem-
brane regions were predicted using the TMPred algorithm (https://embnet.vital-it.ch/software/TMPRED_form.
html. The PD-1 TM was predicted as L168 to I191 and HLA-A2 TM I410 to W435. The chimera with PD-1 trans-
membrane was made with PD1TM Sense and PD1TM Antisense primers. The chimera with HLA-A2 transmem-
brane was made with HLATM Sense and HLATM Antisense primer. Lentivirus was produced using the gag-pol 












HLA TM Sense CAGCCGGCCAGTTCCAAACCATCGTGGGCATCATTGCTGG,
HLA TM Antisense CCAGCAATGATGCCCACGATGGTTTGGAACTGGCCGGCTG.
Super-resolution structured illumination microscopy (SR-SIM) and Zeiss Airyscan microscopy. 
SR-SIM and Airyscan imaging was performed at 37 °C using Plan-Apochromat 63×/1.4 oil DIC M27 objective 
in an Elyra PS.1 microscope (Zeiss). For SR-SIM, images were acquired using 5 phase shifts and 3 grid rotations, 
with 34 µm grating period for the 561 nm laser and filter set 4 (1851-248, Zeiss). Airyscan z-stacks were obtained 
at 0.75 μm steps for a total depth of 12 μm. Stacks were obtained every 30 sec using a fast piezo controller and 
Definite Focus 2.0 (Zeiss) to avoid z-drift between time points. Processed images were projected into a single 
2-D image based on maximum intensity using ImageJ. SR-SIM images were acquired using an sCMOS camera 
and high-resolution Airyscan images were acquired using the LS880 GaAsP detector, both processed using ZEN 
software (Zeiss).
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Flow cytometry, antibodies and dyes. Cells were treated with ionomycin for 15 min at 37 °C in Ringer 
solution containing 2 mM CaCl2. Cells were stained for 30 min on ice and flow cytometry was performed using 
a BD Fortessa (BD Bioscience). Intracellular Ca2+ concentration was monitored with 1 μM Fluo-4 AM (Life 
Technologies) loaded in cells for 30 min at 37 °C prior to the experiment. Surface exposure of phosphatidylser-
ine was detected using 9 ng/ml Annexin V staining in Annexin binding buffer (BioLegend). Microvesicles were 
distinguished from apoptotic bodies using the fixable viability dye eFluor780 dye (eBioscience). Surface staining 
for receptors was carried out for 30 min on ice using the following antibodies: PD-1 APC (MIH4), ICAM-1 
PE (HA58), Transferrin receptor (TfR) PE (M-A712) from BD Biosciences and CD28 PE (CD28.2), LFA-1 PE 
(HI111), CD4 PE (OKT4), CD3 PE/Cy7 (UCHT1), HLA ABC PE (W6/32) from BioLegend. Data were analyzed 
using FlowJo Software (Treestar).
References
 1. Leventis, P. A. & Grinstein, S. The distribution and function of phosphatidylserine in cellular membranes. Annual review of 
biophysics 39, 407–427 (2010).
 2. Nagata, S., Suzuki, J., Segawa, K. & Fujii, T. Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 23, 952–961 (2016).
 3. Suzuki, J., Umeda, M., Sims, P. J. & Nagata, S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468, 834–838 
(2010).
 4. Yu, K. et al. Identification of a lipid scrambling domain in ANO6/TMEM16F. Elife 4, e06901, https://doi.org/10.7554/eLife.06901 
(2015).
 5. Schreiber, R. et al. Expression and function of epithelial anoctamins. J Biol Chem. 285, 7838–7845 (2010).
 6. Yang, H. et al. TMEM16F forms a Ca2+ -activated cation channel required for lipid scrambling in platelets during blood 
coagulation. Cell 151, 111–122 (2012).
 7. Marino, G. & Kroemer, G. Mechanisms of apoptotic phosphatidylserine exposure. Cell research 23, 1247–1248 (2013).
 8. Watanabe, R., Sakuragi, T., Noji, H. & Nagata, S. Single-molecule analysis of phospholipid scrambling by TMEM16F. Proc Natl Acad 
Sci USA 115, 3066–3071 (2018).
 9. Malvezzi, M. et al. Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat Commun. 4, 2367, 
https://doi.org/10.1038/ncomms3367 (2013).
 10. Brunner, J. D., Lim, N. K., Schenck, S., Duerst, A. & Dutzler, R. X-ray structure of a calcium-activated TMEM16 lipid scramblase. 
Nature 516, 207–212 (2014).
 11. Gyobu, S., Ishihara, K., Suzuki, J., Segawa, K. & Nagata, S. Characterization of the scrambling domain of the TMEM16 family. Proc 
Natl Acad Sci USA 114, 6274–6279 (2017).
 12. Hu, Y. et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 213, 2759–2772 
(2016).
 13. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252–264 (2012).
 14. Headland, S. E. et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci Transl Med. 
7, 315ra190, https://doi.org/10.1126/scitranslmed.aac5608 (2015).
 15. Ousingsawat, J. et al. Anoctamin-6 controls bone mineralization by activating the calcium transporter NCX1. Journal of Biological 
Chemistry 290, 6270–6280 (2015).
 16. Anderson, H. C. Matrix vesicles and calcification. Curr Rheumatol Rep. 5, 222–226 (2003).
 17. Ousingsawat, J. et al. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages. 
Nat Comms. 6, 6245, https://doi.org/10.1038/ncomms7245 (2015).
 18. Batti, L. et al. TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States. Cell Rep. 15, 2608–2615 (2016).
 19. Imboden, J. B., Weiss, A. & Stobo, J. D. The antigen recptor on a human T cell line initiates activation by increasing cytoplasmic free 
calcium. J Immunol. 134, 663–65 (1985).
 20. Yaradanakul, A. et al. Massive Ca-induced membrane fusion and phospholipid changes triggered by reverse Na/Ca exchange in 
BHK fibroblasts. The Journal of general physiology 132, 29–50 (2008).
 21. Lariccia, V. et al. Massive calcium-activated endocytosis without involvement of classical endocytic proteins. The Journal of general 
physiology 137, 111–132 (2011).
 22. Jiang, T., Yu, K., Hartzell, H. C. & Tajkhorshid, E. Lipids and ions traverse the membrane by the same physical pathway in the 
nhTMEM16 scramblase. Elife 6, https://doi.org/10.7554/eLife.28671 (2017).
 23. Williams, K. Interactions of polyamines with ion channels. Biochem J. 325(Pt 2), 289–297 (1997).
 24. Ye, W. et al. Phosphatidylinositol-(4, 5)-bisphosphate regulates calcium gating of small-conductance cation channel TMEM16F. Proc 
Natl Acad Sci USA 115, 1667–1674 (2018).
 25. Mirnikjoo, B., Balasubramanian, K. & Schroit, A. J. Suicidal Membrane Repair Regulates Phosphatidylserine Externalization during 
Apoptosis. The Journal of biological chemistry 284, 22512–22516 (2009).
 26. Lee, S. H., Meng, X. W., Flatten, K. S., Loegering, D. A. & Kaufmann, S. H. Phosphatidylserine exposure during apoptosis reflects 
bidirectional trafficking between plasma membrane and cytoplasm. Cell Death Differ. 20, 64–76 (2013).
 27. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119–131 
(2002).
 28. Cocucci, E., Racchetti, G., Podini, P. & Meldolesi, J. Enlargeosome traffic: exocytosis triggered by various signals is followed by 
endocytosis, membrane shedding or both. Traffic 8, 742–757 (2007).
 29. Hilgemann, D. W. & Fine, M. Mechanistic analysis of massive endocytosis in relation to functionally defined surface membrane 
domains. The Journal of general physiology 137, 155–172 (2011).
 30. Bevers, E. M. et al. Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes 
from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 79, 380–388 (1992).
 31. Bevers, E. M. & Williamson, P. L. Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. 
Physiological reviews 96, 605–645 (2016).
 32. Ehlen, H. W. A. et al. Inactivation of anoctamin-6/Tmem16f, a regulator of phosphatidylserine scrambling in osteoblasts, leads to 
decreased mineral deposition in skeletal tissues. J. Bone Miner. Res. 28, 246–259 (2013).
 33. Kumari, S., Curado, S., Mayya, V. & Dustin, M. L. T cell antigen receptor activation and actin cytoskeleton remodeling. Biochim 
Biophys Acta 1838, 546–556 (2014).
 34. Wilson, E. B. The Cell in Development and Heredity. (New York: Macmillan, 1924).
 35. Cooper, S. T. & McNeil, P. L. Membrane Repair: Mechanisms and Pathophysiology. Physiological reviews 95, 1205–1240 (2015).
 36. Idone, V. et al. Repair of injured plasma membrane by rapid Ca2+ -dependent endocytosis. J Cell Biol. 180, 905–914 (2008).
 37. Cocucci, E., Racchetti, G. & Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19, 43–51 (2009).
 38. Jimenez, A. J. et al. ESCRT machinery is required for plasma membrane repair. Science 343, 124–126 (2014).
 39. Griffin, D. A. et al. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy. Hum Mol Genet. 25, 
1900–1911 (2016).
www.nature.com/scientificreports/
13SCIeNTIFIC RepoRts |           (2019) 9:619  | DOI:10.1038/s41598-018-37056-x
 40. Wang, T. M. & Hilgemann, D. W. Ca-dependent nonsecretory vesicle fusion in a secretory cell. The Journal of general physiology 132, 
51–65 (2008).
 41. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nature methods 11, 
783–784 (2014).
 42. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. 
Nature biotechnology 15, 871–875 (1997).
 43. Trudgian, D. C. & Mirzaei, H. Cloud CPFP: a shotgun proteomics data analysis pipeline using cloud and high performance 
computing. Journal of proteome research 11, 6282–6290 (2012).
 44. Trudgian, D. C. et al. CPFP: a central proteomics facilities pipeline. Bioinformatics (Oxford, England) 26, 1131–1132 (2010).
 45. Craig, R. & Beavis, R. C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics (Oxford, England) 20, 1466–1467 
(2004).
 46. Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass 
spectrometry. Nature methods 4, 207–214 (2007).
 47. Trudgian, D. C. et al. Comparative evaluation of label-free SINQ normalized spectral index quantitation in the central proteomics 
facilities pipeline. Proteomics 11, 2790-2797 (2011).
 48. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. Site-directed mutagenesis by overlap extension using the 
polymerase chain reaction. Gene 77, 51–59 (1989).
Acknowledgements
HLA-A2 cDNA was a gift from Dr. Martin Pule, UCL. lentiCRISPR v2 plasmid was a gift from Feng Zhang, 
MIT. We thank David Escors, Djamil Damry, Mehdi Barachian, Mei-Jung Lin and Christopher Tie for help 
with this project and Dr. Criss Hartzell (Emory) for WT mouse TMEM16F plasmid. C.B. was supported by The 
Rosetrees Trust (M155), MRC Doctoral Training Grant (1132770), and the UCL Bogue Fellowship. D.H. and M.F. 
were supported by National Institutes of Health, USA (HL119843, T32DK007257). M.F., R.H. and P.M.P. were 
supported by Medical Research Council (MR/K015826/1) and Biotechnology and Biological Sciences Research 
Council (BB/M022374/1).
Author Contributions
C.B., M.F. and D.H. designed and performed experiments, and wrote the paper. M.K.C. designed experiments 
and wrote the paper. P.M.P., J.S., M.T. and Y.W. designed and performed experiments. R.H. designed experiments.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-37056-x.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
